COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=62537

Amitabha Sengupta

drasengupta@gmail.com

2021-11-08

Not recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

RT-PCR confirmed case of COVID 19 infection. <br/ > Patients with confirmed case of COVID 19 with persistence of lung lesion on HRCT after 6weeks of infection <br/ > Normal hepatic and renal function <br/ > Participants can understand the study and sign informed consent for the study. <br/ >

Previous or concurrent malignancies <br/ > Any previous immunosuppressive therapy/ radiotherapy/ or HIV <br/ > Medical or psychiatric conditions that compromise the patients ability to give informed consent. <br/ >

2

Institute of Postgraduate Medical Education and Research

18

99

India

No restriction on type of patients

0: No restriction on type of patients

60

Change in 6 minutesâ?? walk test at 3; 6 and 12 months after therapy. <br/ >Change in FVC at 3;6 and 12 months after therapy. <br/ >Radiological resolution at 6th and 12 months of therapy <br/ >Timepoint: Baseline; 3; 6 and 12 months

| Declared number of arm (2.0) differs from found arms (3.0)

Phase 2/Phase 3

[{"arm_notes": "", "treatment_id": 2169, "treatment_name": "Mycophenolate mofetil", "treatment_type": "Immunosuppressants", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]